OmarSalahAljitawiMD

Hematologic Oncology

Assistant Professor, Internal Medicine, University Kansas School of Medicine

Dr. Aljitawi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
601 Elmwood Ave
Rochester, NY 14642
Phone+1 585-275-5823

Fax+1 913-588-3996

University of Kansas School of MedicineFellowship, Hematology and Medical Oncology, 2004 - 2007
East Tennessee State University/Quillen College of MedicineResidency, Internal Medicine, 2001 - 2004
University of Jordan Faculty of MedicineClass of 1999

PubMed

3 citations
Vitamin D Receptor Antagonist MeTC7 Inhibits PD-L1.
Negar Khazan, Emily R Quarato, Niloy A Singh, Cameron W A Snyder, Taylor Moore
Cancers. 2023-06-30
3 citations
Prevention of Radiation-Induced Bladder Injury: A Murine Study Using Captopril.
Angela M Groves, Nicole Paris, Eric Hernady, Carl J Johnston, Omar Aljitawi
International Journal of Radiation Oncology, Biology, Physics. 2023-03-15
1 citations
Referral to and receipt of allogeneic hematopoietic stem cell transplantation in older adults with acute myeloid leukemia.
Dharmini Manogna, Jodi J Lipof, Andrea M Baran, Bassil Said, Michael W Becker
Journal of Geriatric Oncology. 2023-01-01

Abstracts/Posters

Increased Early Mortality after Fludarabine and Melphalan Conditioning with Peripheral Blood Grafts in Haploidentical SCT with Post-Transplant Cyclophosphamide
Omar S. Aljitawi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Access and Referral Barriers to Autologous and Allogeneic Hematopoietic Cell Transplantation in Adult Patients with Cancer: A Systematic Review with a Specific Focus o...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018